Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 17Stomach Neoplasms 16Neoplasm Metastasis 11Rectal Neoplasms 10Neoplasms 10Colonic Neoplasms 7Adenocarcinoma 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Esophageal Neoplasms 4Cholangiocarcinoma 4Burkitt Lymphoma 4Advanced Solid Tumors 4Adenocarcinoma Of Esophagus 4Leukemia, Biphenotypic, Acute 3Esophageal Squamous Cell Carcinoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Locally Recurrent Rectal Cancer 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Appendiceal Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Small Bowel Adenocarcinoma × Leucovorin × Clear all
NCT06835387 2026-06-04

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Hoosier Cancer Research Network

Phase 2 Recruiting
36 enrolled
Gastrointestinal

Small Bowel Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡